Goldman Sachs
ZSAN

Goldman Sachs’s Zosano Pharma Corporation ZSAN Stock Holding History

Goldman Sachs’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-309
Closed -$18K – 5817
2020
Q3 		$18K Sell
309
-209
-40% -$9.73K ﹤0.01% 5254
2020
Q2 		$16K Buy
+518
New +$14.6K ﹤0.01% 5140
2018
Q3 		– Sell
-409
Closed -$58K – 5884
2018
Q2 		$58K Buy
+409
New +$61.6K ﹤0.01% 5328

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's ZSAN Position: Q4 2020 in Review

Goldman Sachs sold out of Zosano Pharma Corporation (ZSAN) in Q4 2020, closing a stake of 309 shares — an estimated $18K sold.

Goldman Sachs first reported a position in ZSAN in Q2 2018 and held it in 3 quarters. The position peaked at $58K in Q2 2018. 34 funds tracked by Wall St. Rank hold ZSAN as of Q4 2020.

  • Goldman Sachs reported no remaining Zosano Pharma Corporation position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 309 Zosano Pharma Corporation shares in Q4 2020, an estimated $18K.
  • Goldman Sachs first reported a position in Zosano Pharma Corporation in Q2 2018 and held it in 3 quarters.
  • Goldman Sachs's Zosano Pharma Corporation position peaked at $58K in Q2 2018.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.